FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

RemedyRepack Carvedilol 25 mg Tablet Recall

Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx On…

RemedyRepack Inc. · Indiana, PA

Risk level
Class II
Reported by FDA
Feb 12, 2025
Recall ID
D-0217-2025
Check your lot numberHow we source this data

Summary

RemedyRepack recalled Carvedilol 25 mg Tablet starting Jan 24, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0217-2025 on Feb 12, 2025. Reason: CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit. Status: Terminated.

Why it was recalled

CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.

Product description

Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.

Lot numbers, UPCs & expiration codes

Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.

Where it was sold

FL

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0217-2025
Classification
Class II
Status
Terminated
Recall initiated
Jan 24, 2025
FDA report date
Feb 12, 2025
Quantity
247 blister packs
Recall type
Voluntary: Firm initiated
Recalling firm
RemedyRepack Inc.

Original FDA data

Every field from FDA enforcement report D-0217-2025, exactly as published.

Show all FDA fields
City
Indiana
State
PA
Status
Terminated
Country
United States
Event ID
96191
Address
625 Kolter Dr Ste 4
Code information
Lot #s: J0777493050824, Exp. 5/31/2025; J0787856062124, Exp. 7/31/2025.
Postal code
15701-3571
Report date
Feb 12, 2025
Product type
Drugs
Recall number
D-0217-2025
Classification
Class II
Recalling firm
RemedyRepack Inc.
Product quantity
247 blister packs
Termination date
Jul 17, 2025
Reason for recall
CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC: 70518-3945-00.
Distribution pattern
FL
Recall initiation date
Jan 24, 2025
Initial firm notification
Letter
Center classification date
Feb 3, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0217-2025, published Feb 12, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls